Mini Review: linkages between essential tremor and Parkinson’s disease? by Yiwen Wu et al.
CELLULAR NEUROSCIENCE
MINI REVIEW ARTICLE
published: 31 July 2013
doi: 10.3389/fncel.2013.00118
Mini Review: linkages between essential tremor
and Parkinson’s disease?
Yiwen Wu1, Jianqing Ding1, Yuan Gao1, Shangdi Chen1, Li Li2 and Rena Li3*
1 Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 Department of Health and Kinesiology, Georgia Southern University, Statesboro, GA, USA
3 Center for Hormone Advanced Science and Education (CHASE), International Biomedical Research Training Program (IBRTP), Roskamp Institute, Sarasota, FL, USA
Edited by:
Lawrence Rajendran, University
Zurich, Switzerland
Reviewed by:
Robert Vassar, Northwestern
University, USA
Xin Cheng, Huashan Hospital Fudan
University, China
*Correspondence:
Rena Li, Center for Hormone
Advanced Science and Education,
Roskamp Institute, 2040 Whitfield
Avenue, Sarasota, FL 34243, USA
e-mail: rli@rfdn.org
Essential tremor (ET) and Parkinson’s disease (PD) are two of the most common
movement disorders. Tremors are the primary symptoms of ET and of some PD patients,
the two are often mistaken for each other. Especially since there are no available
differentiate tests for the tremor of ET or PD, the early diagnoses mainly based on clinical
assessments of medical symptoms, family and medication history, and examination by
physicians. There is increasing evidence suggesting an association between ET and PD,
such as a similar tremor frequency, overlapping resting tremors (a typical PD tremor),
postural tremors (mainly in ET patients) in both ET and PD patients, and many ET
patients develop PD later in life. Although it is difficult to make a differential diagnosis
of ET and tremor-dominant PD based on clinical assessment, recent developments of
objective measurements, such as brain imaging, neuropathology, and genetic analysis,
has opened a helpful window for distinguishing ET from PD. In this mini review, we
included literatures of ET and PD studies and discussed various advanced methods for
differential diagnosis between ET and PD such as neuroimaging, genetic markers, tremor
intensity and frequency, and drug-responses.
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INTRODUCTION
Tremor is an involuntary trembling of the body or limbs. In
general, tremor can be classified as “physiological tremor” and
“pathological tremor”. The physiological tremor is a rapid tran-
sient tremor of extremely low amplitude found in the limbs
and sometimes the neck or face of healthy individuals. The
physiological tremor usually is not noticeable and can only be
subtly detected by an electromyogram (EMG) with a frequency
range of 8–10 Hz in most of cases (Freund and Dietz, 1978;
Henneman, 1979). While the cause of physiological tremors is
unknown, noticeable physiological tremors are often increased
with ageing and enhanced by anxiety, fatigue, low blood sugar,
use of caffeine, alcohol, and several medications (Louis et al.,
2000). Pathological tremors usually have the frequency of the
contractions in the range of 4–8 Hz. The most common types
of pathological tremors are observed in people with essential
tremor (ET), Parkinson’s disease (PD), cerebellar tremor, and
dystonic tremor (Elble and Randall, 1976; Deuschl et al., 1998).
Pathological tremors, such as ET and PD, are also commonly
observed in aged populations, without significant gender differ-
ence (Benito-León et al., 2003; Barbosa et al., 2013). The differ-
ential diagnosis of these tremors is important since the treatment
will depend on the specific etiology of each tremor type.
PHENOTYPES OF ET AND PD
There are several types of tremors that are commonly classified
by clinical features, such as resting, action, and posture tremors
(Jankovic and Fahn, 1980). Some of the tremors are known to
be associated with specific movement disorders. For example,
patients with ET mostly suffer from a disabling postural and
action tremors. A typical example of an action tremor is a
tremor that gets most prominent whenever an ET patient tries
to use their hands to do something and ceases typically at rest.
The most recognized and characterized tremors of ET is mainly
involve the hands and forearms while some ET patients also suffer
from head and chin tremors (Louis, 2005; Alonso-Navarro et al.,
2008). The neuropathology of ET is uncertain, although stud-
ies found that the cerebellum, brainstem or thalamus is prob-
ably involved (Deuschl et al., 2000; Kronenbuerger et al., 2007;
Passamonte et al., 2012; Pedrosa et al., 2012). In PD patients,
there is a predominance of resting tremors that occurs in a
body part that is not voluntarily activated and is completely
supported against gravity. The resting tremor usually vanishes
with the initiation of a movement. However, the tremor dis-
appears when the limbs are in extreme rest, such as when
the patient is sleeping. Based on tremor type and frequency,
the PD tremor can also be classified into three phenotypes,
such as Type I characterized by same tremor frequency in
resting and action tremors, type II is different tremor fre-
quency in resting and action tremors, and type III is purely
action tremors including postural tremor (Deuschl et al., 1998).
Because of overlap of resting and action tremors in PD
patients, it is easy to misdiagnose between ET and PD (type II
and III).
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ASSOCIATION BETWEEN ET AND PD
Although ET and PD appear to be two distinct diseases, there is
increasing evidence suggesting an association between ET and PD.
The association between the two movement disorders includes a
similar tremor frequency range of 4–8 Hz in both ET and PD
(although 7–15 Hz tremor frequency is also reported in ET),
overlapping resting tremors (a typical PD tremor) and postural
tremors (mainly in ET patients) in some of ET and PD patients,
and many ET patients develop PD later in life (Simões et al.,
2012). Recent case–control and genetic epidemiological studies
indicate that ET is associated with an increased risk of PD.
For example, 5.9 to 7.1% of PD patients had previously been
diagnosed with ET at least 3–5 years before the onset of PD
(Louis and Frucht, 2007; Tan et al., 2008). The individuals with
family history of postural tremors or ET also showed higher risk of
PD (Lang et al., 1986; Zorzon et al., 2002; Spanaki and Plaitakis,
2009). In addition, functional neuroimaging studies also demon-
strated association between ET and PD. Studies of dopamine
transporter ligands using 125I-beta CIT and 123I-ioflupane have
shown dopaminergic deficiency in the striatum of ET patients
compared to controls (Isaias et al., 2008, 2010). A reduction
of dopamine uptake was also reported in the putman of ET
patients (Brooks et al., 1997). Moreover, studies also found PD
neuropathological marker, Lewy bodies, in the locus coeruleus
of some ET patients (Louis et al., 2007). However, the specific
pathophysiology of the tremors in both diseases requires further
investigation.
DIFFERENTIAL DIAGNOSIS OF ET AND TREMOR DOMINANT
PD PATIENTS
There is no biomarker for to differentiate the tremors of ET
and PD except by clinical assessment. The difficulty with diag-
nosing early PD has been highlighted in several recent clini-
cal trials, especially with relatively high clinical diagnostic error
rates for PD and ET. As reported from multiple clinical studies,
about 30–50% of ET patients are misdiagnosed as “false” ET,
PD or no ET (Schrag et al., 2000; Jain et al., 2006; Quinn et al.,
2011). While there is no concrete evidence on why there is such
poor accuracy in diagnosing ET, it is possible that a certain
subtype of ET may be involved in clinical investigations. For
example, a subset of ET patients that developed PD (ET-PD)
over time may express different clinical characteristics and neu-
ropathological features compare to stable ET patients who do
not develop PD. A recent study showed that ET-PD patients had
fewer widespread postural and/or action tremors or cerebellar
signs and required fewer ET medications than stable ET patients
(Simões et al., 2012). In addition, it is pretty difficult to diagnosis
ET when the patients have overlapping tremors with PD, such
as resting tremors. Studies showed 19% of ET patients have rest
tremors and rigidity while sustained posture tremors are also
found in some PD patients (Louis et al., 2001; Cohen et al., 2003;
Dotchin and Walker, 2008). Since ET is reported as a risk of PD
and often occurs several years prior to the onset of PD, increasing
interest in developing objective measurements, such as brain
image and genetic analysis, is critical for early diagnosis of ET and
the prevention of PD.
CURRENT APPROACHES FOR DIAGNOSIS OF ET AND PD
There has been considerable interest in neuroimaging, genetic
markers, tremor intensity and frequency and drug-response for
diagnosis of ET and PD. Although there is no sufficient evidence
for the causes of ET and tremors in PD, we have listed some
commonly used methods for the diagnosis of ET and PD.
(1) Neuroimaging is currently used to provide objective
measures of dysfunction in the brain in ET and PD, such as
positron emission computed tomography (PET), and magnetic
resonance imaging (MRI). [18F] fluorodeoxyglucose (FDG)-PET
imaging, which assesses brain metabolism and synaptic activity,
has demonstrated increased pallidothalamic and pontine activ-
ity associated with a relative reduction in cortical motor regions
in PD (Eidelberg et al., 1997; Wang et al., 2013). A number of
imaging studies indicated clear differences between ET and PD in
terms of basal ganglia involvement, such as the striatal [123I]beta-
CIT binding ratios in ET were within normal ranges while
reduced specific binding was evident in the putamen and caudate
nucleusin PD (Asenbaum et al., 1998). Using electrode implan-
tation by stereotactic cranial computed tomography (CT) and
stereotactic high resolution MRI as reference image, studies mea-
sured intraoperatively thalamic local field potentials simultane-
ously with EMG in ET and PD patients and found that within
the ventral lateral posterior nucleus of the thalamus (VLp) indi-
vidual tremor-related electrophysiological signatures exist in ET
and PD tremors (Pedrosa et al., 2012). However, the analyzed
tremor-related local field potentials activity in the VLp is a sur-
gical method, which limits its application in many clinical prac-
tices, except when performing deep brain stimulation (DBS), an
effective treatment for ET and PD (Koller et al., 2000; Lyons et al.,
2001; Rehncrona et al., 2003; Blomstedt et al., 2007). The 123I-
ioflupane ligand with single-photon emission CT was recently
approved in the United States to aid in PD diagnosis. While
neuroimaging biomarkers have been extensively utilized in PD
(Wang et al., 2013), appropriate use of 123I-ioflupane scan in
cases of possible ET with marked asymmetry or other Parkin-
sonian features is recommended and would help in detection of
tremulous PD cases or cases of PD with additional ET (Bajaj et al.,
2013).
(2) Genetic approaches are the next steps for diagnosis of
ET and PD. Although the gene accounting for the majority of
ET patients has not been identified, twin studies suggested a
large role of genes over environment in ET by doubling concor-
dance in monozygotic than that in dizygotic twins (Tanner et al.,
2001; Lorenz et al., 2004) and the difference of concordance
rates between monozygotic and dizygotic twins were increased
in aged population (Deuschl et al., 1998). Three distinct loci
were identified with linkage to ET as ETM1, ETM2 and ETM3
located at chromosome 3q13, 2p24 and 6p23 regions, respectively
(Gulcher et al., 1997; Illarioshkin et al., 2002; Shatunov et al.,
2006). However, most of the ET loci vary with regions, such
as ETM2 was highly linked to ET in American, Spanish and
Korean cohorts, but negatively linked in Czech, Italian, Latvian,
Singaporean, German, Danish and French cohorts (see review
by Testa, 2013). PD is the result of a loss of dopamine in the
substantia nigra. Several studies demonstrated genetic markers
for PD, such as a-synuclein (SNCA), MAPT, leucine-rich repeat
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kinase 2 gene (LRRK2), DJ-1, PARK16–18, (Mata et al., 2011).
Recent studies also showed that genetic variants of leucine-rich
repeat and Ig domain containing 1 (LINGO-1) gene could be risk
factor for ET (Zhou et al., 2012) and polymorphism of leucine-
rich repeat and Ig domain containing 2 (LINGO-2) is associated
with risk of PD (Su et al., 2012). However, there are no genetic
studies on ET-PD patients which may be important in identifying
any genetic features of the subset ET-PD patients from stable ET
patients and provide some insight on understanding the genetic
association between ET and PD.
(3) Drug response is a clinical method to measure the patient’s
response to a specific drug treatment to confirm the proposed
diagnosis. For example, if the cause of a tremor is PD, it may
respond well to medication such as levodopa or other dopaminer-
gicmedications. The limitation of using patient drug response as a
confirmation of clinical diagnosis is also obvious. Studies showed
that patients at early stage of PD with prominent tremors may
not response to L-dopa or other dopaminergic medicine well; the
medication response may not confirm the clinical diagnosis of
early PD (Marjama-Lyons and Koller, 2000). Furthermore, about
30% of ET patients do not respond to the medication propra-
nolol, the most widely accepted treatment for ET, while improve-
ment was reported in PD tremors (Koller and Herbster, 1987;
Koller and Vetere-Overfield, 1989). Alone, drug-response might
not be very beneficial for differential diagnosis of ET and PD.
(4) Tremor intensity and frequency analysis is another interest-
ing tool for differential diagnosis of ET and PD. Studies examined
asymmetry of tremors on the hands of PT and ET patients,
and demonstrated that the intensity of tremors was significantly
asymmetric in both diseases while the frequency (number of
repetitions per second) were more symmetric in ET and asym-
metric in PD (Farkas et al., 2006). The different type of tremors
between ET and PD were also reported by independent inves-
tigations. In general, ET starts with low amplitude tremors and
gradually develops to disabling tremors. The tremor frequency
may decrease while tremor amplitude (magnitude/strength) may
increase as ET progresses (Mostile et al., 2012). Studies found that
intensity of tremors were markedly attenuated during walking
relative to resting ET patients and the intensity and frequency
of Parkinsonian tremors were increased while walking than while
resting (Uchida et al., 2011). However, ET resting tremors can’t
be differentiated from PD resting tremors both clinically or by
detecting the intensity and frequency of tremors. The relationship
between tremor intensity or frequency in ET and PD is con-
troversial. An inverse correlation between tremor intensity and
centre frequency was found in ET patients while patients with
PD showed only significant correlation between centre frequency
and the hand with more severe tremor, not in the other hand
(Machowska-Majchrzak et al., 2012). Other studies reported a
significant inverse correlation between tremor intensity and cen-
tre frequency in both hands in patients with PD (Farkas et al.,
2006). Further investigation on developing differential diagnosis
on tremor intensity and frequency between ET and PD is needed.
CONCLUSION
Although ET and PD differ in etiology and are characterized with
distinct symptoms, misdiagnosis between the two is still common
due to lacking of objective differential measurement. Identifying
different pathological tremors in ET and PD would not only help
differential diagnosis of ET and early stage of PD, but plays critical
role in developing specific therapeutic strategy and treatment for
the two major movement disorders. Especially, as ET has been
reported as a risk of PD and often occurs several years prior
to onset of PD, developing noninvasive and sensitive objective
measurements is critical for early diagnosis of ET and prevention
of PD.
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